Connect with us

Research

In vitro antifungal activities of medicinal plants used for treatment of candidiasis in Pader district, Northern Uganda

Published

on

Betty Akwongo, Esezah K. Kakudidi, Anthony M. Nsubuga, Morgan Andama, Mary Namaganda, Patience Tugume, Savina Asiimwe, Godwin Anywar & Esther Katuura 

Abstract

Background

The emergence of multidrug resistant Candida species to available drugs has led to renewed interest in the use of herbal medicines globally. This study scientifically verified antifungal effectiveness of five commonly used plant species in Pader district, against selected pathogenic candida strains.

Methods

Powdered roots of Momordica foetida, Sansevieria dawei and Distimake dissectus; and stem barks of Khaya anthotheca and Mitragyna rubrostipulata were extracted sequentially using petroleum ether and methanol, respectively; and total water extraction at 24.4 °C (maceration), 60 °C (decoction) and boiling water at 87 °C (hot water infusion). Extracts and their combinations, positive controls (amphotericin B, and fluconazole) and negative control (80% dimethyl sulfoxide, verified to be tolerable concentration to the tested Candida species) were screened and verified for their antifungal activity against Candida albicans (ATCC: American Type Culture Collection reference strain 10231, ATCC 90028, 0770a and 0796), C. glabrata (VVc 004, ATCC 2950) and C. tropicalis (ATCC 750 and 0210) using agar well diffusion and broth micro-dilution, respectively.

Results

Aqueous extract (24.4 °C) of M. rubrostipulata (ZOI: 18.00 ± 1.00 to 38.33 ± 0.17; MIC: 3.13 ± 0.00 to 20.83 ± 4.17; MFC: 12.50 ± 0.00 to 200.00 ± 0.00), methanol extract of K. anthotheca (10.11 ± 0.31 to 15.11 ± 0.65; 1.04 ± 0.26 to 12.50 ± 0.00; 12.50 ± 0.00 to 100.00 ± 0.00), and combination of aqueous extract (60 °C) of D. dissectus + methanol extract of K. anthotheca (7.89 ± 0.26 to 19.67 ± 0.37; 0.78 ± 0.00 to 50.00 ± 0.00; 12.50 ± 0.00 to 200.00 ± 0.00) exhibited broad spectrum antifungal activities and were fungistatic against all tested Candida species, which comprised 8 clinical/control and susceptible/resistant strains. None of the conventional drugs used demonstrated broad spectrum antifungal activity across all tested Candida species/strains.

Conclusion

Methanol extract of K. anthotheca, aqueous extract (24.4 °C) of M. rubrostipulata, and combination of aqueous extract (60 °C) of D. dissectus + methanol extract of K. anthotheca could be effective in the treatment of candidiasis. They demonstrated potential broad spectrum antifungal activity against different species and strains of tested Candida than the fluconazole and amphotericin B drugs. Their fungistatic nature showed their ability to inhibit fungal growth. Hence, these extracts/extract combination can offer better treatment option for candidiasis if they are standardized and also their active curative compounds isolated and made into antifungal drugs.

View full article on BMC

Mak Editor

Research

CARTA Fellow Tamale on Building Systems, Shaping Policy and Transforming Lives beyond the PhD

Published

on

Dr. Andrew Tamale, College of Veterinary Medicine, Animal Resources and BioSecurity (CoVAB), Makerere University, Kampala Uganda, East Africa. Photo. CARTA.

A PhD can spark impact that extends far beyond academia. Meet CARTA graduate Andrew Tamale, whose journey demonstrates the multiplier effect of research capacity strengthening—from helping transform doctoral training and generating evidence that informed safer fish consumption practices, to strengthening One Health approaches for outbreak preparedness in Uganda and beyond. 

Read full story

Source: CARTA News & Updates Issue 105

Mark Wamai

Continue Reading

Research

CARTA Fellow Anywar Appointed UTANA Subject Matter Expert, Talks Medicinal Plants

Published

on

Dr. Godwin Anywar, Department of Plant Sciences, Microbiology and Biotechnology, College of Natural Sciences (CoNAS), Makerere University. Kampala Uganda, East Africa.

Godwin Anywar, cohort 6, Makerere University, was appointed as a Subject Matter Expert on the Manuscript Technical Evaluators team of the Uganda Textbook Academic and Non-Fiction Authors Association (UTANA) on August 31, 2026. In this role, Godwin will contribute to the qualitative, academic, and pedagogical assessment of manuscripts submitted under the Capacity Building for School Books Project (CB-SP). The four-year project, implemented jointly with the Department of Teacher Education and Training Development (TETD) of Uganda’s Ministry of Education and Sports (MoES), aims to strengthen authorship and support the development of school books in Uganda’s education sector.

He was also featured in Uganda’s New Vision on July 26, 2026, in a special report on Uganda’s medicinal plants.

Source: CARTA News & Updates Issue 105

Mark Wamai

Continue Reading

Research

Makerere Hosts TERID Hub Early Career Researchers Grant Writing Workshop

Published

on

The Emerging and Re-emerging Infectious Diseases (TERID) Hub continued its efforts to strengthen the capacity of 17 early career researchers (ECRs) (10 men, 7 women) on an institutional level by holding a grant writing workshop from September 8 - 11, 2026, at Makerere University, Kampala Uganda, East Africa.

The Emerging and Re-emerging Infectious Diseases (TERID) Hub continued its efforts to strengthen the capacity of early career researchers (ECRs) on an institutional level by holding a grant writing workshop from September 8 – 11, 2026, at Makerere University. The workshop, attended by 17 ECRs (10 men, 7 women), strengthened participating researchers’ capacity by equipping them with critical skills to secure competitive funding. The intensive sessions bridged the gap between innovative academic concepts and fundable proposals, focusing heavily on decoding complex funder criteria and structuring compelling narratives. Participants prioritized the CONNECT-VAX call, which closely aligns with the Hub’s core work, and formed two groups: one on vaccine research and development capacity, the other on public trust and demand for vaccines manufactured in Africa.

Through this call, the Hub engaged collaborators from West Africa (Sierra Leone) and East Africa (Kenya and Tanzania) in developing two of its grant applications. Individual concepts on leishmaniasis, leptospirosis, tuberculosis, and pharmaceutical inventory management were also advanced, bringing the total to eight proposals across four funding calls, including Makerere University Research and Innovation Fund (MAK-RIF 8), Wellcome, and WHO/TDR.

To date, the Hub’s grant writing effort has attracted over USD 700,000. The workshop reinforced the Hub’s commitment to mentoring early-career researchers and championing research in emerging and re-emerging infectious diseases.

Source: CARTA News & Updates Issue 105

Mark Wamai

Continue Reading

Trending